# Cerliponase Alfa (Genetical Recombination) Injection 150mg (ブリニューラ脳室内注射液１５０ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3959422A1028). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3959422A1028
- **Product name (Japanese):** ブリニューラ脳室内注射液１５０ｍｇ
- **English title:** Cerliponase Alfa (Genetical Recombination) Injection 150mg
- **Active ingredient:** セルリポナーゼ アルファ（遺伝子組換え）
- **Active ingredient (INN):** Cerliponase Alfa (Genetical Recombination)
- **Strength / unit:** １５０ｍｇ５ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 395 Enzyme preparations (酵素製剤)
- **Manufacturer:** ＢｉｏＭａｒｉｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｊａｐａｎ
- **NHI price (reference only):** JPY 1327645 per １５０ｍｇ５ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3959422A1028
- **JSON:** https://www.nifujipharma.com/api/drugs/3959422A1028

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Cerliponase%20Alfa%20(Genetical%20Recombination)%20Injection%20150mg%20(%E3%83%96%E3%83%AA%E3%83%8B%E3%83%A5%E3%83%BC%E3%83%A9%E8%84%B3%E5%AE%A4%E5%86%85%E6%B3%A8%E5%B0%84%E6%B6%B2%EF%BC%91%EF%BC%95%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%203959422A1028#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.